PlainPharmaWatch

CMS Open Payments · Program Year 2024

Massachusetts

Massachusetts received $230,339,559.39 in pharmaceutical-industry payments to 16,112 physicians and 37 teaching hospitals across 224,425 transactions.

$230.3M
Total payments
$74.9M
To physicians
$152.1M
To teaching hospitals
#4
of 59 states

In CMS Open Payments Program Year 2024, pharmaceutical and medical-device companies reported $230.3M in payments to 16,112 physicians and 37 teaching hospitals in Massachusetts. That ranks Massachusetts #4 of 59 states and territories (1.7% of the US total), averaging $4.6K per physician. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

The verdict

Massachusetts pairs top-10% payment volume with a hospital-heavy payment mix.

#4
of 59 states
1.7%
of the national total
32.5%
to physicians vs. hospitals
16,112
physicians paid

What the Data Shows for Massachusetts

Massachusetts's Open Payments file is hospital-weighted: 66.0% of $230.3M went to 37 teaching hospitals ($4.1M each), with 32.5% on 16,112 physicians.

On the national dollar ranking it is still #4 of 59 (1.7% of US payments). Average transaction $1.0K. Leading nature of payment: "Royalty or License" at $131.0M (56.9% of the state file; top-three natures 79.6%).

Massachusetts sits in the 95th percentile (top-10 nationally). Just above: Pennsylvania ($305.4M). Just below: Texas ($224.7M). For context: top-ranked California ($342.4M) is 1.5× larger than Massachusetts. CMS Sunshine Act framework and methodology.

Physician vs Hospital Payments

How pharmaceutical payments in Massachusetts are distributed between physicians and teaching hospitals.

Physician Payments

$74.9M

32.5% of total · 16,112 recipients · $4.6K avg

Teaching Hospital Payments

$152.1M

66.0% of total · 37 hospitals · $4.1M avg

Payment Breakdown by Type

Massachusetts has 16 types of pharmaceutical payments. "Royalty or License" accounts for 56.9%.

Nature concentration in Massachusetts

Top three Open Payments natures are 79.6% of state dollars; residual is every other reported nature

Royalty or License$131.0MConsulting Fee$31.1MCompensation for Services Ot…$21.3MAll other natures (13)$46.9M

Payment categories in Massachusetts

Top categories by total reported dollar volume

1. Royalty or License$131.0M2. Consulting Fee$31.1M3. Compensation for Services…$21.3M4. Grant$15.3M5. Food and Beverage$6.6M6. Travel and Lodging$5.5M7. Acquisitions$5.4M8. Debt Forgiveness$4.9M9. Charitable Contribution$2.5M10. Education$2.0M
Payment Type Amount Transactions
Royalty or License $131.0M 1,055
Consulting Fee $31.1M 8,295
Compensation for Services Other Than Consulting $21.3M 4,532
Grant $15.3M 475
Food and Beverage $6.6M 189,247
Travel and Lodging $5.5M 13,405
Acquisitions $5.4M 19
Debt Forgiveness $4.9M 1,061
Charitable Contribution $2.5M 393
Education $2.0M 4,000
Space Rental or Facility Fees $1.8M 221
Honoraria $1.3M 428
Long-Term Medical Supply or Device Loan $814.8K 311
Compensation for Faculty or Speaker (Medical Education) $492.2K 284
Gift $213.3K 606
Entertainment $8.6K 93

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Source: CMS Open Payments Database Industry payments to physicians and teaching hospitals · 2024

What Massachusetts totals can and cannot tell you

The aggregate payment figure for Massachusetts measures reportable industry–physician engagement inside this state's geographic footprint for Program Year 2024, not any one physician's or hospital's relationship with industry. CMS collects the data under the Physician Payments Sunshine Act; manufacturers must report transfers of value above the de minimis threshold. The file does not capture DTC advertising, internal R&D, wholesale drug pricing, or salary support that is not a reportable transfer of value.

Correlations between payment receipt and prescribing appear in peer-reviewed work for specific drugs and specialties, but this page's state total does not establish causation. Open the company and recipient detail pages for category and year-over-year cuts.

View saved (states)
Download Massachusetts's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.